May 27, 2009 the zelrix i patch contained 3 grams g of sumatriptan gel loaded with 120 mg of sumatriptan succinate. Sumatriptan iontophoretic transdermal system for acute. Jun 03, 2016 the sumatriptan iontophoretic transdermal patch is called zecuity. Sumatriptan transdermal iontophoretic patch np101zelrix. Oct 19, 2007 the primary objective was to compare the pharmacokinetics pk of np101 sumatriptan iontophoretic transdermal patch with the currently approved oral, subcutaneous injection and nasal spray formulations of imitrex in healthy volunteers and to assess the bioavailability relative to the 6 mg subcutaneous injection. Patients with access to a computer and an internet connection may download them from the products website. In the same study that assessed different possible patch polymers, 14 the authors also investigated the application of iontophoretic technology to the mcazone patch and determined that based on the observed sumatriptan transdermal flux of 284. Jan 22, 2020 sumatriptan succinate is a white to offwhite powder that is freely soluble in water. The sumatriptan iontophoretic transdermal system zecuity was a combination drug patch, manufactured by teva pharmaceuticals, designed.
Zecuity sumatriptan iontophoretic is a prescription drug used to treat migraine headaches. Food and drug administration fda is investigating the risk of serious burns and potential permanent scarring with the use of zecuity sumatriptan iontophoretic transdermal. Sumatriptan iontophoretic patch for migraine request pdf. Zecuity sumatriptan iontophoretic transdermal systemdescription. Zecuity is a serotonin 5ht1b1d receptor agonist triptan indicated for the acute treatment of migraine, with or without aura, in adults who have a clear migraine diagnosis. A phase i, singlecenter, openlabel, randomized singledose, two way crossover study to compare the pharmacokinetics of two np101 patch applications sumatriptan iontophoretic transdermal system with and without controlled heat. Jan 20, 20 the fda has approved zecuity sumatriptan iontophoretic transdermal system for the treatment of acute migraine in adults with or without aura zecuity is a batterypowered skin patch that. Zecuity migraine patch sumatriptan iontophoretic transdermal. The novel iontophoretic transdermal sumatriptan patch. Fda investigating migraine patch skin reactions webmd. A sumatriptan iontophoretic transdermal system for the acute. The zecuity sumatriptan iontophoretic transdermal system was marketed for acute treatment of migraine.
Sumatriptan transdermal route precautions mayo clinic. Zecuity patch fda prescribing information, side effects. Sumatriptan transdermal skin patch is used to treat acute migraine headaches with or without aura in adults. The iontophoretic transdermal system formulation of. Us9427578b2 pharmacokinetics of iontophoretic sumatriptan. Oct 28, 2019 zecuity sumatriptan iontophoretic transdermal system. Authormapper searches journal articles and plots the location of the authors on a map. A sumatriptan patch zecuity for migraine the medical. Zecuity sumatriptan iontophoretic patch medication.
An iontophoretic transdermal system its skin patch formulation of sumatriptan for the acute treatment of migraine attacks was approved by the us food and drug administration in january 20. The sumatriptan iontophoretic transdermal system zecuity was a combination drug patch, manufactured by teva pharmaceuticals, designed to treat migraine attacks. The patch was applied to the upper arm, alternating right and left sides. Sumatriptan transdermal route proper use mayo clinic. Zecuity sumatriptan iontophoretic transdermal system product. The device delivers a subcutaneous injection of 6 mg sumatriptan, without the use of a needle. The patient instructions for use for sumatriptan iontophoretic transdermal system are appended to the prescribing information. The sumatriptan iontophoretic transdermal system tds zecuity, nupathe, malvern, pa, a novel approach to the acute treatment of migraine, circumvents the gastrointestinal tract by using lowlevel electrical energy to transport sumatriptan across the skin. Zecuity sumatriptan iontophoretic transdermal system, the first skin patch for the treatment of migraine in adults, has been approved by the. Zecuity is a serotonin 5ht 1b1d receptor agonist triptanindicated for the acute treatment of migraine with or without aura in adults 1 limitations of use. This medicine comes with a patient information leaflet. A new delivery system is the sumatriptan iontophoretic transdermal patch zecuity, which is a singleuse transdermal patch containing 86 mg of sumatriptan that delivers 6. Zecuity sumatriptan is a transdermal system patch selective serotonin receptor agonist used to treat acute migraine with or without aura in adults. Safety problems with a transdermal patch for migraine headache.
Zecuity sumatriptan iontophoretic transdermal system is a prescription acute medication for treating migraine attacks. What drugs, substances, or supplements interact with zecuity. Sep 30, 2019 zecuity is an iontophoretic transdermal system tds or a deviceassisted skin patch that uses a mild electrical current to deliver sumatriptan through your skin. Zecuity sumatriptan iontophoretic transdermal system zecuity sumatriptan iontophoretic transdermal system preparation zecuity is a singleuse transdermal system tds or patch. Sumatriptan iontophoretic transdermal system medicinenet. The zelrix i patch contained 3 grams g of sumatriptan gel loaded with 120 mg of sumatriptan succinate. Earlier this month, the fda announced its investigation of the risk for serious burns and potential permanent scarring with the use of the zecuity sumatriptan iontophoretic transdermal system. Zecuity patch sumatriptan iontophoretic transdermal system.
Sumatriptan also reduces substances in the body that can trigger headache pain, nausea, sensitivity to light and sound, and other migraine symptoms. Zecuity is a serotonin 5ht1b1d receptor agonist indicated for the acute treatment of migraine, with or without aura, in adults who have a clear migraine diagnosis. Teva previously nupathe has developed a sumatriptan transdermal patch for the treatment of migraine and migraine related nausea. Zecuity patch fda prescribing information, side effects and. This transdermal system bypasses the gastrointestinal tract, as it uses low electrical current to move sumatriptan transdermally into the subcutaneous tissue. In clinical trials, sumatriptan tds has provided consistent drug delivery.
Transdermal sumatriptan is delivered through a single. Zecuity contains the drug, sumatriptan, which has been previously. Zecuity sumatriptan iontophoretic transdermal system or patch is a medication prescribed to treat acute migraines with or without auras in adults. May 02, 2017 patients were advised to stop using the zecuity patch immediately. No more than two zecuity patches should be used in any 24hour period. An iontophoretic transdermal system its skin patch formulation of sumatriptan for the acute treatment of migraine attacks was approved by the us food and. Use only after a clear diagnosis of migraine has been established 1. Sumatriptan succinate is a white to offwhite powder that is freely soluble in water. Transdermal patch of sumatriptan offers sustained relief. Transdermal patch of sumatriptan offers sustained relief of.
The fda has approved a sumatriptan iontophoretic transdermal system zecuity teva for acute treatment of migraine in adults. Autoinjectors with needles have been previously available in europe and north america for several years. Zecuity is an iontophoretic transdermal system tds or a deviceassisted skin patch that uses a mild electrical current to deliver sumatriptan through your skin. The singleuse, batterypowered patch offers relief of migrainerelated nausea mrn as well as migraine headache pain. To optin for investor email alerts, please enter your email address in the field below and select at least one alert option. More recently, a transdermal delivery system has been. Ask your doctor or pharmacist if you have any questions. Important safety information what important information should i know about zecuity. Sumatriptan iontophoretic transdermal system zecuity is antimigraine drug that is delivered through the skin or transdermally. Pdf sumatriptan transdermal iontophoretic patch np101. The reservoir card contains 2 nonwoven pads and 2 different gel formulations.
Sumatriptan is a headache medicine that narrows blood vessels around the brain. Optumrx specializes in the delivery, clinical management and affordability of prescription medications and consumer health products. Upon activation of the patch and application of an electrical current, the positively charged drug moves away from the anode, through the patients skin, and into. A recent development in drug delivery systems includes delivery of medication via a skin patch. Zecuity sumatriptan iontophoretic transdermal system.
We note that your july 9, 20, submission to snda 202278s001 includes final printed labeling fpl for your package insert, patient package insert, and instructions for use. Phase iii studies with an iontophoretic transdermal patch zelrixzecuity started in july 2008. Sumatriptan works in the brain to relieve the pain from migraine headaches. The patch was withdrawn less than 10 months after its. Fda, teva pharmaceuticals announce sales suspension of. Sumatriptan iontophoretic transdermal system neurology. Sumatriptan iontophoretic transdermal system for the acute. Sumatriptan transdermal advanced patient information. Find patient medical information for sumatriptan transdermal on webmd including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Sumatriptan transdermal iontophoretic patch np101 zelrix. The sumatriptan iontophoretic transdermal patch is called zecuity. On june 10, 2016 teva pharmaceuticals sent a socalled dear doctor letter to health care providers about zecuity, its migraine drug patch. Sumatriptan comes with a patient information leaflet. It is also available in oral, intranasal, and injectable formulations.
The amount of drug delivered was determined by iontophoretic current. Since marketing of the zecuity patch began in september 2015, a large number of patients have reported they experienced burns or scars on the skin where the patch was worn. A second zecuity patch should be used no sooner than 2 hours after activation of first. Us9427578b2 us14185,485 us201414185485a us9427578b2 us 9427578 b2 us9427578 b2 us 9427578b2 us 201414185485 a us201414185485 a us 201414185485a us 9427578 b2 us9427578 b2 us 9427578b2 authority us united states prior art keywords sumatriptan patch ma treatment subject prior art date 20080619 legal status the legal status is an assumption and is not a legal conclusion. Transdermal delivery of sumatriptan for the treatment of. Availability of zecuityr sumatriptan iontophoretic transdermal system, first and only transdermal patch system for the acute treatment of. Philadelphiaan iontophoretic transdermal delivery of sumatriptan provided statistically significant improvement compared with placebo for rapid, consistent, and sustained relief of acute migraine headache, according to research presented at the 14th congress of the international headache society. Gastrointestinal symptoms, such as nausea and vomiting, occur almost universally at one time or another in patients during a migraine attack. Iontophoresis is a noninvasive method of delivering a drug through the skin using a low electrical current. It can relieve migraine headache pain and the nausea that sometimes comes. Safety problems with a transdermal patch for migraine. This sumatriptan transdermal system may be a good choice for migraineurs with severe nausea or vomiting, those with intolerable triptanrelated. It belongs to the group of medicines called triptans. The us food and drug administration fda approved the patch in january 20 for the acute treatment of migraine in adults.
It is a serotonin 5ht 1b1d receptor agonist that is used for the acute treatment of migraine headaches in adults. Sumatriptan is a serotonin1 sumatriptan transdermal teva adisinsight. Phase i study to compare np101sumatriptan iontophoretic. Transdermal patch an overview sciencedirect topics. Food and drug administration fda has approved sumatriptan iontophoretic transdermal system zecuity, nupathe inc for acute treatment of adults who have migraine with or without aura. Availability of zecuity sumatriptan iontophoretic transdermal system, first and only transdermal patch system for the acute treatment of migraine. Zecuity sumatriptan iontophoretic patch medication junction. The fda has approved zecuity sumatriptan iontophoretic transdermal system for the treatment of acute migraine in adults with or without aura zecuity is a batterypowered skin patch that. Zecuity iontophoretic transdermal system is composed of an iontophoretic device and a drug reservoir card. Zecuity is no longer on the market as a treatment for migraine.
After submitting your request, you will receive an activation email to the requested email address. Iontophoretic transdermal delivery of sumatriptan a new delivery system is the sumatriptan iontophoretic transdermal patch zecuity, which is a singleuse transdermal patch containing 86 mg of sumatriptan that delivers 6. The zecuity migraine patch sumatriptan iontophoretic transdermal system was developed by nupathe, inc. The device was brought to market in september 2015 by teva pharmaceuticals, which had acquired nupathe. Each zecuity iontophoretic transdermal system contains 86 mg sumatriptan base as the succinate salt in an aqueous formulation.
1085 1569 858 1337 1308 997 1199 1153 930 908 952 884 795 1402 1426 703 546 888 933 1370 1269 206 778 77 713 1596 1257 450 148 660 713 1367 926 986 325 1037 1150 1516 262 242 851 334 1115 848 602 729 549 625 645 869 560